Jane Street Group, LLC Acelrx Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.18 - $0.29 $3,970 - $6,396	22,056 Added 90.26%	46,493 $11,000
Q1 2022 May 17, 2022	SELL	$0.28 - $0.61 $2,818 - $6,139	-10,065 Reduced 29.17%	24,437 $7,000
Q4 2021 Feb 15, 2022	BUY	$0.49 - $1.02 $2,095 - $4,361	4,276 Added 14.15%	34,502 $19,000
Q3 2021 Nov 16, 2021	SELL	$0.93 - $1.51 $23,749 - $38,560	-25,537 Reduced 45.8%	30,226 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.03 - $1.7 $57,435 - $94,797	55,763 New	55,763 $77,000
Q1 2021 May 18, 2021	SELL	$1.25 - $2.77 $16,593 - $36,771	-13,275 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$1.18 - $1.98 $2,047 - $3,435	1,735 Added 15.03%	13,275 $16,000
Q3 2020 Nov 17, 2020	SELL	$1.01 - $1.81 $7,495 - $13,432	-7,421 Reduced 39.14%	11,540 $16,000
Q2 2020 Aug 17, 2020	BUY	$1.03 - $1.69 $19,529 - $32,044	18,961 New	18,961 $23,000
Q3 2019 Nov 14, 2019	SELL	$2.1 - $2.87 $203,966 - $278,754	-97,127 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.1 - $3.93 $149,234 - $279,281	71,064 Added 272.66%	97,127 $246,000
Q1 2019 May 16, 2019	BUY	$2.35 - $3.83 $61,248 - $99,821	26,063 New	26,063 $91,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $4.6 $32,450 - $57,412	-12,481 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.13 - $4.2 $26,584 - $52,420	12,481 New	12,481 $42,000
Q4 2017 Feb 15, 2018	SELL	$1.75 - $5.5 $20,373 - $64,031	-11,642 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.9 - $4.6 $33,761 - $53,553	11,642	11,642 $54,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.